Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

60 Degrees Pharmaceuticals (SXTP) Assets Average (2023 - 2025)

Historic Assets Average for 60 Degrees Pharmaceuticals (SXTP) over the last 3 years, with Q3 2025 value amounting to $5.4 million.

  • 60 Degrees Pharmaceuticals' Assets Average fell 746.38% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 746.38%. This contributed to the annual value of $6.8 million for FY2024, which is 4913.72% up from last year.
  • Per 60 Degrees Pharmaceuticals' latest filing, its Assets Average stood at $5.4 million for Q3 2025, which was down 746.38% from $5.1 million recorded in Q2 2025.
  • Over the past 5 years, 60 Degrees Pharmaceuticals' Assets Average peaked at $8.5 million during Q4 2023, and registered a low of $5.1 million during Q2 2025.
  • For the 3-year period, 60 Degrees Pharmaceuticals' Assets Average averaged around $6.7 million, with its median value being $6.4 million (2024).
  • Its Assets Average has fluctuated over the past 5 years, first plummeted by 2883.77% in 2024, then crashed by 746.38% in 2025.
  • 60 Degrees Pharmaceuticals' Assets Average (Quarter) stood at $8.5 million in 2023, then decreased by 22.17% to $6.6 million in 2024, then fell by 17.52% to $5.4 million in 2025.
  • Its Assets Average was $5.4 million in Q3 2025, compared to $5.1 million in Q2 2025 and $5.9 million in Q1 2025.